HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carmen Guillén-Ponce Selected Research

Gemcitabine

2/2024Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.
1/2022Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.
1/2021Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial.
11/2020Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I results.
1/2019Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carmen Guillén-Ponce Research Topics

Disease

12Neoplasms (Cancer)
04/2024 - 02/2008
6Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 02/2008
4Adenocarcinoma
02/2024 - 01/2019
4Pancreatic Neoplasms (Pancreatic Cancer)
02/2024 - 01/2019
2Breast Neoplasms (Breast Cancer)
04/2024 - 01/2012
2Neutropenia
02/2024 - 01/2021
2Thrombocytopenia (Thrombopenia)
02/2024 - 01/2022
2Disease Progression
12/2022 - 01/2021
1Ovarian Neoplasms (Ovarian Cancer)
04/2024
1Hepatocellular Carcinoma (Hepatoma)
06/2022
1Enterocolitis
01/2022
1Febrile Neutropenia
01/2022
1Infections
01/2021
1Prostatic Neoplasms (Prostate Cancer)
12/2016
1Neoplasm Metastasis (Metastasis)
10/2015
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
11/2010
1Renal Cell Carcinoma (Grawitz Tumor)
01/2010
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2010
1Colonic Neoplasms (Colon Cancer)
02/2008
1Rectal Neoplasms (Rectal Cancer)
02/2008

Drug/Important Bio-Agent (IBA)

5GemcitabineFDA Link
02/2024 - 01/2019
4Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2010
4Fluorouracil (Carac)FDA LinkGeneric
02/2024 - 02/2008
4130-nm albumin-bound paclitaxelIBA
02/2024 - 01/2019
4Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2024 - 02/2008
3Leucovorin (Folinic Acid)FDA Link
02/2024 - 11/2020
3Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 02/2008
2Panitumumab (Vectibix)FDA Link
12/2022 - 10/2015
2Bevacizumab (Avastin)FDA Link
11/2020 - 02/2008
2Monoclonal AntibodiesIBA
10/2015 - 02/2008
2Transforming Growth Factor-beta Type I ReceptorIBA
11/2009 - 06/2009
1Estrogen ReceptorsIBA
04/2024
1Poly Adenosine Diphosphate RiboseIBA
04/2024
1Cell-Free Nucleic AcidsIBA
12/2022
1roblitinibIBA
06/2022
1spartalizumabIBA
06/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2022
1pembrolizumabIBA
01/2021
1MicroRNAs (MicroRNA)IBA
03/2019
1AlbuminsIBA
01/2019
1Albumin-Bound PaclitaxelFDA Link
01/2019
1Cetuximab (Erbitux)FDA Link
10/2015
1Epithelial Cell Adhesion MoleculeIBA
11/2010
1Imatinib Mesylate (Gleevec)FDA Link
01/2010
1Sunitinib (Sutent)FDA Link
01/2010
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
11/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2008
1Capecitabine (Xeloda)FDA Link
02/2008

Therapy/Procedure

8Drug Therapy (Chemotherapy)
01/2022 - 02/2008
3Therapeutics
04/2024 - 11/2020
1Castration
12/2016
1Adjuvant Chemotherapy
01/2012
1Radiotherapy
02/2008